Obsessive-Compulsive Disorder News

Body dysmorphic disorder may negatively impact quality of life and body image during pregnancy, especially during first and third trimesters, highlighting the need for interventions and support for pregnant women, researchers reported.

A new study further confirmed the association between obsessive-compulsive disorder and psoriasis, stressing the need for dermatologists to be vigilant.

In a new study published in the Journal of Drugs in Dermatology, researchers discussed how and why dermatologists have a significant role to play in the diagnosing and addressing of body dysmorphic disorder.

Significant dose-response associations were found for transcranial magnetic stimulation and transcranial direct current stimulation across several mental disorders, including schizophrenia and depression, according to research.

Body dysmorphic disorder and appearance preoccupation were relatively common among youth, especially adolescent girls, according to a study published in Journal of the American Academy of Child & Adolescent Psychiatry.

Maternal obsessive-compulsive disorder was associated with increased adverse pregnancy, delivery and neonatal outcomes, according to findings from two cohort studies published in JAMA Network Open.

The FDA has granted 510(k) clearance to Neuronetics Inc. for its obsessive-compulsive disorder motor threshold cap technology for NeuroStar Advanced Therapy for Mental Health.

MIAMI BEACH, Fla. —Treatment with psilocybin significantly reduced symptoms at 8 weeks in patients with severe obsessive-compulsive disorder, according to a poster at the American Society of Clinical Psychopharmacology annual meeting.

HHS has released its “Roadmap for Behavioral Health Integration,” which details policy solutions to help integrate mental health and substance use care into large health care systems.